Drug Trial Radar · NCT03417388
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
2,476
Actual
Start
Feb 9, 2018
Primary completion
Feb 15, 2025
Study completion Apr 16, 2027
Sponsor
- Lead sponsor
- Cedars-Sinai Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- United States Department of Defense; University of Florida
- First posted
- Jan 31, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Ischemia-IMT (Ischemia-Intensive Medical Treatment Reduces Events in Women with Non-Obstructive CAD), subtitle: Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR) trial is a multicenter, prospective, randomized, blinded outcome evaluation (PROBE design) evaluating intensive statin/ACE-I (or ARB)/aspirin treatment (IMT) vs. usual care (UC) in 4,422 symptomatic women patients with symptoms and/or signs of ischemia but no obstructive CAD. The hypothesis is that IMT will reduce major adverse coronary events (MACE) 20% vs. UC. The primary outcome is first occurrence of MACE as death, nonfatal MI, nonfatal stroke/transient ischemic attack (TIA) or hospitalization for heart failure or angina. Secondary outcomes include quality of life, time to "return to duty"/work, health resource consumption, angina, cardiovascular (CV) death and primary outcome components. Events will be adjudicated by an experienced Clinical Events Committee (CEC). Follow-up was planned to be 3-years using 50 sites: primarily VA and Active Duty Military Hospitals/Clinics and a National Patient-Centered Clinical Research Network (PCORnet) clinical data research network (CDRN)(OneFlorida Consortium). The number of sites were increased and follow up was modified to continue until the last patient enrolled was followed until trial follow up was completed. Recruitment was complete January 6, 2024. This study is being conducted to determine whether intensive medication treatment to modify risk factors and vascular function in women patients with coronary arteries showing no flow limit obstruction but with cardiac symptoms (i.e., chest pain, shortness of breath) will reduce the patient's likelihood of dying, having a heart attack, stroke/TIA or being hospitalized for cardiac reasons. The results will provide evidence data necessary to inform future guidelines regarding how best to treat this growing population of patients, and ultimately improve the patient's cardiac health and quality of life and reduce health-care costs.
Conditions
- Coronary Artery Disease
Interventions
High dose potent statinDrug
The IMT-assigned women will receive high-dose, potent statin (atorvastatin 40-80 mg/d or rosuvastatin 20-40mg) class of lipid-lowering medications.
ACE-I (lisinopril) or ARB (losartan)Drug
Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) are widely prescribed for primary hypertension.
Aspirin 81 enteric coated tablet dailyDrug
Will be recommended to IMT women without contraindications or bleeding risk.
Lifestyle CounselingBehavioral
The PACE Lifestyle Assessment Intervention which is a program to assist with smoking cessation, weight loss, and exercise.
Quality of Life QuestionnairesBehavioral
Quality of Life Questionnaires will be obtained.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary outcome is MACE, defined as first occurrence of all-cause death, non-fatal MI, non-fatal stroke, or hospitalization for angina or HF.Time frame: Within 5 years
Locations
81 sites in 2 countries. Site status is shown where the registry gives one.
Cardiology Associates of Mobile, Inc.
Mobile, Alabama
Dignity Health-Mercy Gilbert Medical Center
Gilbert, Arizona
Dignity Health-St. Joseph
Phoenix, Arizona
University of Arizona
Tucson, Arizona
University of Arkansas
Little Rock, Arkansas
Cedars-Sinai Heart Institute
Los Angeles, California
UCLA Medical Center
Los Angeles, California
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Torrance, California
Georgetown University
Washington D.C., District of Columbia
Clearwater Cardiovascular Consultants Clinical Research
Clearwater, Florida
South Palm Cardiovascular Research Institute
Delray Beach, Florida
Family Medicine at Eastside Community Practice
Gainesville, Florida
Family Medicine at Hampton Oaks Medical Plaza (Adults and Peds)
Gainesville, Florida
Internal Medicine at Tower Hill
Gainesville, Florida
Family Medicine at Haile Plantation (Adults & Peds)
Gainesville, Florida
Malcom Randall VA Medical Center
Gainesville, Florida
Cardiovascular Clinic at UF Health UF
Gainesville, Florida
Internal Medicine at UF Health Medical Plaza
Gainesville, Florida
Spring Hill Cardiology
Gainesville, Florida
Family Medicine at 4th Ave
Gainesville, Florida
Family Medicine at Old Town (Adults and Peds)
Gainesville, Florida
Baptist Health
Jacksonville, Florida
University of Florida, Jacksonville
Jacksonville, Florida
Naval Hospital Jacksonville
Jacksonville, Florida
Mayo Clinic Jacksonville
Jacksonville, Florida
UF Primary Care at Lake City SW
Lake City, Florida
UF Primary Care at Lake City West
Lake City, Florida
Charles H. Croft MDPA
Melbourne, Florida
Daytona Heart Group
Multiple Locations, Florida
Southwest Florida Research Institute
Naples, Florida
Cardiovascular Instititute of Central Florida
Ocala, Florida
Ocala Research Institute Inc.
Ocala, Florida
Orlando Health
Orlando, Florida
Naval Hospital Pensacola
Pensacola, Florida
Cardiovascular Center of Sarasota
Sarasota, Florida
Advent Sebring
Sebring, Florida
James A. Haley Veterans Hospital
Tampa, Florida
AdventHealth Tampa - Pepin Heart Institute
Tampa, Florida
Interventional Cardiac Consultants
Tampa, Florida
BayCare Medical Group
Tampa, Florida
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.